Prescription drug · NDA AUTHORIZED GENERIC
Clindamycin Phosphate and Benzoyl Peroxide NDC 68682-133
Clindamycin phosphate 10 mg/g; Benzoyl peroxide 37.5 mg/g · Gel · Topical · Oceanside Pharmaceuticals
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68682-133-50 | 68682013350 | 1 BOTTLE, PUMP in 1 CARTON (68682-133-50) / 50 g in 1 BOTTLE, PUMPMarketed from Oct 2, 2023 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clindamycin Phosphate and Benzoyl Peroxide
- Generic name (nonproprietary)
- clindamycin phosphate and benzoyl peroxide
- Active ingredients
- Clindamycin phosphate — 10 mg/gBenzoyl peroxide — 37.5 mg/g
- Dosage form
- Gel
- Route
- Topical
- Labeler
- Oceanside Pharmaceuticals
- Product type
- Prescription drug
- Marketing category
- NDA authorized genericApplication NDA 050819
- Marketing start
- Listing expires
- Other FDA classes
- Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
- Identifiers
- Product ID 68682-133_e1c50b8b-5ad3-4d84-a751-3fe7137646d4SPL ID e1c50b8b-5ad3-4d84-a751-3fe7137646d4SPL set ID 1d53ec2b-d33d-4245-99f1-e41b30303660RxCUI 1598470UNII EH6D7113I8, W9WZN9A0GMUPC 0368682133509
- Pharmacologic class
- Lincosamide Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468682013350followed by a unit qualifier and the quantityPackage 68682-0133-50. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/3.75% is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Clindamycin Phosphate and Benzoyl Peroxide Gel is a combination of clindamycin phosphate (a lincosamide antibacterial) and benzoyl peroxide indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under NDA 050819
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Onextonclindamycin phosphate and benzoyl peroxide | Clindamycin phosphate 10 mg/g; Benzoyl peroxide 37.5 mg/g | GelTopical | Bausch Health US, LLC | 0187-3050 |
| Clindamycin Phosphate and Benzoyl Peroxide | Clindamycin phosphate 10 mg/g; Benzoyl peroxide 25 mg/g | GelTopical | Oceanside Pharmaceuticals | 68682-132 |
| Acanyaclindamycin phosphate and benzoyl peroxide | Clindamycin phosphate 10 mg/g; Benzoyl peroxide 25 mg/g | GelTopical | Bausch Health US, LLC | 13548-132 |